Massimo Volpe to Risk Assessment
This is a "connection" page, showing publications Massimo Volpe has written about Risk Assessment.
Connection Strength
0.230
-
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention. High Blood Press Cardiovasc Prev. 2020 Oct; 27(5):373-377.
Score: 0.038
-
Prognostic relevance of GRACE risk score in Takotsubo syndrome. Eur Heart J Acute Cardiovasc Care. 2020 Oct; 9(7):721-728.
Score: 0.036
-
Reclassification of Hypertensive Outpatients According to New US Guidelines on High Blood Pressure. Am J Hypertens. 2019 01 01; 32(1):77-87.
Score: 0.034
-
Search of multiple markers of organ damage for better cardiovascular risk stratification in hypertension: Role of "SHATS" syndrome in the clinical practice. Int J Cardiol. 2018 07 15; 263:154-155.
Score: 0.033
-
Adding markers of organ damage to risk score models improves cardiovascular risk assessment: Prospective analysis of a large cohort of adult outpatients. Int J Cardiol. 2017 Dec 01; 248:342-348.
Score: 0.031
-
2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document. High Blood Press Cardiovasc Prev. 2017 Sep; 24(3):313-329.
Score: 0.031
-
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev. 2021 Jan; 28(1):5-11.
Score: 0.010
-
[A unique case of secondary takotsubo syndrome]. G Ital Cardiol (Rome). 2018 Apr; 19(4):239-241.
Score: 0.008
-
Long-Term Outcome of Acute Coronary Syndromes in Young Patients. High Blood Press Cardiovasc Prev. 2017 Mar; 24(1):77-84.
Score: 0.008